CDMOs Clean Up Act: Environmental Responsibility

The pharmaceutical sector, which is one of the highest emitters of carbon, is no exception. According to Deloitte, more ...

March 31, 2025 | Monday | Analysis
Xcellbio announces new partnership in Australia to improve potency for rapid cell therapy manufacturing

Xcell Biosciences Australia Pty Ltd, an Australian affiliate of the San Francisco-based instrumentation company focused ...

March 26, 2025 | Wednesday | News
ENCell signs MoU with Cell Resources Corp to pave way for market entry in Japan

ENCell Co., Ltd., a South Korean biotech company specialising in advanced biopharmaceutical contract development and man...

March 14, 2025 | Friday | News
Taiwan's Amaran Biotech signs MoU with Nippon to expand CDMO business

Amaran Biotechnology Inc., a subsidiary of OBI Pharma specialising in Contract Development and Manufacturing Organizatio...

March 12, 2025 | Wednesday | News
WuXi XDC and AbTis announce strategic partnership to advance next-generation ADCs

WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specialisi...

March 11, 2025 | Tuesday | News
Vetter boosts pharmaceutical storage capacity with major warehouse expansion

Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced a significant exp...

March 11, 2025 | Tuesday | News
Syngene acquires first manufacturing facility in the US

Syngene International Limited, a global contract research, development, and manufacturing organization (CRDMO), has anno...

March 11, 2025 | Tuesday | News
Boehringer Ingelheim enhances biopharmaceutical contract manufacturing services in China

Boehringer Ingelheim’s biopharmaceutical facility in Shanghai, China, meets the conditions to participate in a reg...

March 5, 2025 | Wednesday | News
WuXi Biologics introduces new platform to boost recombinant protein and plasmid DNA production

China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...

March 4, 2025 | Tuesday | News
WuXi Biologics Successfully Passes Japan PMDA GMP Inspection Again

WuXi Biologics, a leading global contract research, development, and manufacturing organization (CRDMO...

February 28, 2025 | Friday | News
CDMO Live Debuts as BioPharma Manufacturing Sector Approaches $200 Billion

CDMO Live has emerged as the definitive industry gathering, bringing together Europe's leading pharmaceutical outsourcin...

February 26, 2025 | Wednesday | News
WuXi XDC and LigaChem Biosciences expand MoU to accelerate ADC development

China-based WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization...

February 25, 2025 | Tuesday | News
Jubilant Biosys strengthens footprint in Europe for Biologics and Antibody Drug Conjugate services

Jubilant Biosys Innovative Research Services Pte Limited, Singapore (JBIRSPL), a subsidiary of Jubilant Biosys Limited, ...

February 13, 2025 | Thursday | News
“China and Asia are already the global leaders of Antibody-drug conjugates”

Chime Biologics has a vision to make biologics more accessible and affordable. How does this vision drive your day-to-da...

February 1, 2025 | Saturday | Opinion
Korea's Lotte Biologics unveils antibody-drug conjugate platform SoluFlex Link

At the 2025 J.P. Morgan Healthcare Conference held recently, now in its 43rd year, South Korea-based Lotte Biologics unv...

January 20, 2025 | Monday | News
Lyndra Therapeutics inks manufacturing services collaboration with Thermo Fisher for long-acting oral therapies

Lyndra Therapeutics, a clinical-stage biopharmaceutical company pioneering long-acting oral therapies, has announced a s...

January 16, 2025 | Thursday | News
Samsung Biologics extends collaboration with LigaChem Biosciences for ADC development in Korea

South Korea-based Samsung Biologics, a global contract development and manufacturing organisation (CDMO), has announced&...

January 9, 2025 | Thursday | News
Partnership in China to build new ecosystem for antibody-drug conjugates

Porton Pharma Solutions and Dragon Sail Pharmaceutical (Shanghai) have signed a strategic cooperation agreement in Guili...

December 24, 2024 | Tuesday | News